We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Mindy M. Chou
Mindy M. Chou
Products
PRODUCTS
Lannett Co., Inc.
Mindy M. Chou
Price:
$117.00
View
Regeneron Pharmaceuticals, Inc.
Mindy M. Chou
,
Patric C. Klotzbuecher
, and
Sony Mathews
Price:
$117.00
View
NIH Clinical Center Pharmacy Department
Mindy M. Chou
and
Djamila Harouaka
Price:
$117.00
View
Perrigo New York, Inc.
Mindy M. Chou
Price:
$117.00
View
Sofie Co.
Mindy M. Chou
Price:
$117.00
View
Nutravail, LLC
Mindy M. Chou
Price:
$117.00
View
ULTRAtab Laboratories, Inc.
Mindy M. Chou
Price:
$117.00
View
Cosmetica Laboratories, Inc.
Mindy M. Chou
Price:
$117.00
View
NCM USA Bronx LLC
Mindy M. Chou
Price:
$117.00
View
BASF Corp.
Mindy M. Chou
Price:
$117.00
View
View All Products by Mindy M. Chou
Upcoming Events
14
Jul
EU-MDR Postmarket Surveillance: Best Practices for Medical Device Regulatory, Compliance & Quality Specialists
15
Jul
Predictive Compliance Risk and Quality Management: A New Digital Paradigm for the Post-COVID-19 World
15
Jul
How to Address Medical Device Sample Size Issues: What Regulatory and Quality Professionals Absolutely Must Know
16
Jul
Micro-learning, Macro-Compliance: Improving GxP Compliance with Modern Learning Techniques
16
Jul
Inspection, Measuring and Test Equipment: A Regulatory Approach
22
Jul
Overcoming Comparability Issues in Regenerative Medicines Manufacturing: The Latest on Cell and Gene Therapy Regulation
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
New Data Shows Gilead’s Remdesivir Improves Recovery for COVID-19 Patients
FDA to Resume Domestic Inspections Using New Assessment System
Pfizer and BioNTech Nab Fast Track Status for Two COVID-19 Vaccines
Vela’s Automated COVID-19 Test Gains CE Mark
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
